Position in ABBV
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$2,452,986
+$358,340 QoQ
Shares Held
9,748
+1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#1,802
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Formidable Asset Management, LLC holds $28,439,814 across 10 Drug Manufacturers - General names. ABBV ranks #3 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,607 | $13,921,785 | |
| 2 | JNJ |
Johnson & Johnson
|
23,878 | $6,064,295 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
9,748 | $2,452,986 | |
| 4 | AMGN |
Amgen Inc
|
5,152 | $1,865,642 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,070 | $1,422,495 | |
| 6 | PFE |
Pfizer Inc
|
56,869 | $1,369,405 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,040 | $520,884 | |
| 8 | NVS |
Novartis AG
|
2,430 | $380,829 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,452,986 | 9,748 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $2,094,646 | 9,631 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $2,335,853 | 10,223 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $2,406,626 | 10,394 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,965,715 | 10,590 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,218,816 | 10,590 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,860,696 | 10,471 | Shares | Sole | 2025-02-19 | |
| 2024-09-30 | $2,154,704 | 10,911 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,901,642 | 11,087 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,968,865 | 10,812 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $855,744 | 5,522 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $829,518 | 5,565 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $745,595 | 5,534 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $958,451 | 6,014 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $923,277 | 5,713 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $800,562 | 5,965 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $929,681 | 6,070 | Shares | Sole | 2022-08-18 | |
| 2022-03-31 | $988,060 | 6,095 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,877,456 | 13,866 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,697,981 | 15,741 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,068,052 | 9,482 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $957,638 | 8,849 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $846,699 | 7,902 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $503,379 | 5,747 | Shares | Sole | 2020-12-14 | |
| 2020-06-30 | $548,138 | 5,583 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $405,330 | 5,320 | Shares | Sole | 2020-06-01 | |
| No filing history on record for this holder in this stock. | ||||||